New Allon publication confirms potential in stroke conditionsJuly 24, 2006 Journal Article confirms mechanism of Allon's drugsJuly 5, 2006 Angiotech Selects Independent Sales Rep in Japan for Contour Threads(TM) Product LineJuly 20, 2006 Angiotech appoints Jeffrey P. Walker as Senior Vice President, Research and DevelopmentJuly 6, 2006 AnorMED reports fiscal 2007 first quarter results and upcoming milestonesJuly 27, 2006 AnorMED completes enrollment in Phase III trial for MOZOBIL in stem cell transplant in multiple myelomaJuly 10, 2006 Aspreva Pharmaceuticals Reports Second Quarter 2006 ResultsJuly 26, 2006 Aspreva Pharmaceuticals: Mycophenolate Mofetil Approved for Treatment of Lupus Nephritis in MalaysiaJuly 19, 2006 Aspreva Pharmaceuticals Announces Appointment of Dr. Richard Jones as SVP, Clinical and Regulatory AffairsJuly 11, 2006 Aspreva Announces Preliminary Revenues for Second Quarter 2006July 10, 2006 British Columbia Institute of Technology $507,000 to Link Research with IndustryJuly 12, 2006 Cardiome Announces Interim Phase 2A Results for Oral RSD1235July 24, 2006 Cardiome to Hold Conference CallJuly 21, 2006 Cardiome and Astellas Amend AgreementJuly 10, 2006 Cardiome Provides Clinical UpdateJuly 7, 2006 CB Richard Ellis has Inexpensive Office/ Research and Development Space Available July 25, 2006 J. Kevin Buchi Joins the Celator Pharmaceuticals Board of DirectorsJuly 31, 2006 Celator Pharmaceuticals Announces Positive European Patent Decision For CombiPlex Technology Used to Develop Fixed-Ratio Combination ChemotherapiesJuly 17, 2006 Chemokine Therapeutics to Present Data on its Blood Vessel Regeneration Compound CTCE-0324 at 2006 Gordon Research Conference on Chemotactic CytokinesJuly 20, 2006 Improved performance puts Chromos Technology Platform among best in classJuly 11, 2006 Mr. Ron MacKenzie joins Chromos' Board of DirectorsJuly 6, 2006 CIHR/MSFHR Bioinformatics Industrial Research Rotation Program: Call for Company ParticipantsJuly 25, 2006 INEX Provides Timeline for Spin-out of Tekmira Pharmaceuticals CorporationJuly 18, 2006 Alnylam and INEX Accelerate Collaboration on Systemic Delivery of RNAi TherapeuticsJuly 17, 2006 Inex Revises Plan of Arrangement to Spin Out Tekmira Pharmaceuticals CorporationJuly 11, 2006 Lions Capital Manages $7,500,000 Financing of Sirius Genomics
August 1, 2006 Med Biogene Inc. receives renewed ethics board approval from Vancouver Coastal Health AuthorityAugust 1, 2006 Med BioGene Inc.'s Chief Scientific Officer to present at prestigous P.O.E.T.I.C. Conference to be held July 19-21 in Banff, AlbertaJuly 11, 2006 MIGENIX Reports Fourth Quarter and Fiscal Year 2006 Financial ResultsJuly 13, 2006 MIGENIX Fourth Quarter and Fiscal Year 2006 Financial Results Conference Call & Web Cast NotificationJuly 6, 2006 Pacgen Biopharmaceuticals Names Dr. Alan Moore and Mr. Kevin McGarry to the Board of DirectorsJuly 17, 2006 Protiva Biotherapeutics to Block Inex Pharmaceuticals ReorganizationJuly 19, 2006 Protiva Completes $5.6 Million Convertible Debt FinancingJuly 13, 2006 Protox acquires Phase II cancer program from Neurocrine and U.S. Public Health ServiceJuly 20, 2006 QLT announces Q2 results for 2006 and provides further guidanceJuly 27, 2006 QLT to repurchase up to 13 million common shares, this represents approximately 15% of shares outstandingJuly 27, 2006 QLT announces Visudyne ® sales for second quarter of 2006July 17, 2006 Protox announces new institutional investor |
